Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor and scientific conferences: TIDES USA: Oligonucleotide and Peptide Therapeutics (Presentation) Thursday, May 16, 2024 (4:45 p.m. ET) H.C. Wainwright 2nd An